Zacks Investment Research on MSN

Is it the right time to add Insulet stock to your portfolio?

Insulet PODD is well-poised to grow in the coming quarters due to the strength of its Omnipod 5 platform. The company is strongly executing against its long-term priorities to drive penetration, ...

Assessing DexCom (DXCM) Valuation As Shares Lag Over The Past Year

DexCom overview and recent share performance DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last ...